From: Augmented reality for stroke rehabilitation during COVID-19
Outcome | MCID/MDC | PP analysis (n=39) | ITT analysis (n=84) | ||
---|---|---|---|---|---|
 |  | AR-Centre (n = 23) | AR-Home (n = 16) | AR-Centre (n = 59) | AR-Home (n = 25) |
 |  | % Post-pre > MCID | % Post-pre > MCID | % Post-pre > MCID | % Post-pre > MCID |
FMA-UE | 5.25 (MCID) [49] | 34.78% | 37.50% | 13.56% | 12.00% |
FMA-LE | 3.57 (MDC) [52] | 52.17% | 62.50% | 20.34% | 40.00% |
BBS | 2.7 (MDC) [53] | 43.48% | 37.50% | 16.95% | 24.00% |
FAC | 4\(^*\) | 4.35% | 6.25% | 1.69% | 4.00% |
BI | 1.85 (MCID) [50] | N/A | 37.50% | N/A | 24.00% |
SF-12v2 PCS | 2.5 (MCID) [51] | 47.83% | 68.75% | 18.64% | 44.00% |
SF-12v2 MCS | 10\(^{**}\) | 30.43% | 12.50% | 11.86% | 8.00% |